$MMSI

Peterson Neil W. sold $1.8M of MMSI

Peterson Neil W. (CHIEF OPERATING OFFICER) sold 21,449 shares of MERIT MEDICAL SYSTEMS INC (MMSI) at $85.00 ($1.82M total) on 2026-08-04.

Original reporting
SEC EDGAR · Peterson Neil W.
Published Aug 5, 2026, 5:22 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Aug 5, 2026, 5:27 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
alphai market briefInsider activity
Primary signal
$MMSI
Neutral
medium confidence
Mentioned
$MMSI
Relevance
6/10
alphai data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$MMSINeutralLow
01

Why it matters

The only new fact is the disclosed sale size, price, and post-transaction holdings. No operational, financial, or regulatory developments are included.

02

Market read

Traders may note insider selling as a sentiment datapoint, but there is no fundamental catalyst in the text.

03

What to watch

The filing does not state tax, option exercise, or planned selling rationale beyond the open-market sale code, so interpreting it as a signal is low-confidence.

Relevance 6/10Novelty 3/10Timing: filed 2026-08-05, transaction dated 2026-08-04

Background

This is an SEC Form 4 insider transaction disclosure for Merit Medical Systems (MMSI) by COO Peterson Neil W.

Company-level read

Ticker impact

$MMSINeutralMedium confidence
Context

Insider Form 4 shows COO Peterson Neil W sold 21,449 shares of Merit Medical Systems at $85.00 on 2026-08-04 for about $1.82M.

Expected impact

Likely limited near-term impact; any reaction would be sentiment-driven and typically fades unless paired with other disclosures.

Evidence & confidence

Form 4 insider sales are common and this text provides no accompanying guidance, operational change, or regulatory/legal development. The absence of a stated 10b5-1 plan can raise scrutiny, but the article contains no additional context to infer a material negative catalyst.

Market effects

Minimal. Insider selling in a single medtech name rarely changes sector expectations without corroborating news.

None indicated.

None indicated.

Counterpoint

The sale could be for diversification or personal liquidity needs, and the lack of a stated 10b5-1 plan does not automatically imply negative information.

Key entities

  • MERIT MEDICAL SYSTEMS INC

    US-listed company whose insider sale is disclosed via Form 4.

  • Peterson Neil W.

    Chief Operating Officer who sold 21,449 shares in an open-market transaction.

Related articles

$MMSIMedAI 8/10

Merit Medical (MMSI) Q2 2026 Earnings Call Transcript

Merit Medical Systems (MMSI) reported Q2 2026 revenue of $418.8 million, up 10% GAAP, and non-GAAP EPS of $1.19. Non-GAAP operating margin was 22.6% and free cash flow $51.9 million. The company raised 2026 revenue guidance to $1.631B-$1.643B and non-GAAP EPS to $4.25-$4.35, and guided Q3 revenue to $408M-$413M.

$MMSIMedAI 8/10

These Analysts Increase Their Forecasts On Merit Medical Systems After Strong Q2 Results - Merit Medical

Merit Medical Systems Inc (NASDAQ:MMSI) posted better-than-expected earnings for the second quarter on Thursday. The company posted adjusted EPS of $1.19, beating market estimates of 96 cents per share. The company’s sales came in at $418.843 million versus expectations of $405.268 million. Merit Medical Systems raised its FY2026 adjusted EPS guidance from $4.01-$4.15 to $4.25-$4.35 and increased its sales forecast from $1.612 billion-$1.634 billion to $1.631 billion-$1.643 billion.

$MMSIMedAI 8/10

Merit Medical Systems (NASDAQ:MMSI) Reports Bullish Q2 CY2026, Stock Soars

Medical device company Merit Medical Systems (NASDAQ: MMSI) reported Q2 CY2026 results beating Wall Street’s revenue expectations, with sales up 9.5% year on year to $418.8 million. The company’s full-year revenue guidance of $1.64 billion at the midpoint came in 1.1% above analysts’ estimates. Its non-GAAP profit of $1.19 per share was 24% above analysts’ consensus estimates. Is now the time to buy Merit Medical Systems? Find out by accessing our full research report, it’s free.

$MMSIHigh

MERIT MEDICAL SYSTEMS INC (MMSI): Results of Operations and Financial Condition

MERIT MEDICAL SYSTEMS INC (MMSI) filed an SEC Form 8-K — Results of Operations and Financial Condition. EX-99.1 2 mmsi-20260730xex99d1.htm EX-99.1 Exhibit 99.1 ​ ​ ​ ​ ​ ​ ​ ​ Contacts: ​ ​ ​ ​ PR/Media Inquiries: Sarah Comstock Merit Medical Investor Inquiries: Mike Piccinino, CFA, IRC ICR Healthcare ​ ​ +1-801-432-2864 +1-443-213-0509 ​ ​ sarah.comstock@merit.com mike.piccinino@i